BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 24936031)

  • 1. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
    Fenger JM; London CA; Kisseberth WC
    ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma.
    Morello E; Martano M; Buracco P
    Vet J; 2011 Sep; 189(3):268-77. PubMed ID: 20889358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating CXCR4 expression in canine appendicular osteosarcoma.
    Fan TM; Barger AM; Fredrickson RL; Fitzsimmons D; Garrett LD
    J Vet Intern Med; 2008; 22(3):602-8. PubMed ID: 18466248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Immunology and Immunotherapy of Canine Osteosarcoma.
    Mason NJ
    Adv Exp Med Biol; 2020; 1258():199-221. PubMed ID: 32767244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Of dogs and men: comparative biology as a tool for the discovery of novel biomarkers and drug development targets in osteosarcoma.
    Rankin KS; Starkey M; Lunec J; Gerrand CH; Murphy S; Biswas S
    Pediatr Blood Cancer; 2012 Mar; 58(3):327-33. PubMed ID: 21990244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
    Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
    BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative biology of human and canine osteosarcoma.
    Mueller F; Fuchs B; Kaser-Hotz B
    Anticancer Res; 2007; 27(1A):155-64. PubMed ID: 17352227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the biology and management of canine osteosarcoma.
    Chun R; de Lorimier LP
    Vet Clin North Am Small Anim Pract; 2003 May; 33(3):491-516, vi. PubMed ID: 12852233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial genome and functional defects in osteosarcoma are associated with their aggressive phenotype.
    Jackson M; Serada N; Sheehan M; Srinivasan S; Mason N; Guha M; Avadhani N
    PLoS One; 2018; 13(12):e0209489. PubMed ID: 30576337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of P16 expression in canine appendicular osteosarcoma.
    Murphy BG; Mok MY; York D; Rebhun R; Woolard KD; Hillman C; Dickinson P; Skorupski K
    BMC Vet Res; 2017 Jun; 13(1):189. PubMed ID: 28633676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The animal-dependent risk factors in canine osteosarcomas.
    Sapierzyński R; Czopowicz M
    Pol J Vet Sci; 2017 Mar; 20(2):293-298. PubMed ID: 28865206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between absolute tumor burden and serum bone-specific alkaline phosphatase in canine appendicular osteosarcoma.
    Sternberg RA; Pondenis HC; Yang X; Mitchell MA; O'Brien RT; Garrett LD; Helferich WG; Hoffmann WE; Fan TM
    J Vet Intern Med; 2013; 27(4):955-63. PubMed ID: 23734720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics.
    Simpson S; Dunning MD; de Brot S; Grau-Roma L; Mongan NP; Rutland CS
    Acta Vet Scand; 2017 Oct; 59(1):71. PubMed ID: 29065898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
    Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
    Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of optimal water fluoridation on the incidence and skeletal distribution of naturally arising osteosarcoma in pet dogs.
    Rebhun RB; Kass PH; Kent MS; Watson KD; Withers SS; Culp WTN; King AM
    Vet Comp Oncol; 2017 Jun; 15(2):441-449. PubMed ID: 26762869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
    Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
    Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine and canine models of appendicular osteosarcoma.
    Fan TM
    Curr Protoc Pharmacol; 2007 Jun; Chapter 14():Unit 14.1. PubMed ID: 21948160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy of canine osteosarcoma with canine bone marrow stem cells, bone morphogenetic protein and carboplatin in an in vivo model.
    Rici REG; Will SEAL; Luna ACL; Melo LF; Santos AC; Rodrigues RF; Leandro RM; Maria DA
    Vet Comp Oncol; 2018 Dec; 16(4):478-488. PubMed ID: 29781255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous regression of osteosarcoma in four dogs.
    Mehl ML; Withrow SJ; Seguin B; Powers BE; Dernell WS; Pardo AD; Rosenthal RC; Dolginow SZ; Park RD
    J Am Vet Med Assoc; 2001 Sep; 219(5):614-7. PubMed ID: 11549088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations.
    Angstadt AY; Thayanithy V; Subramanian S; Modiano JF; Breen M
    Cancer Genet; 2012 Nov; 205(11):572-87. PubMed ID: 23137772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.